MB Baltic Science Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 57,651 |
| - |
| 22,326 |
| 22,326 |
| - |
| 100.00 |
| 38.73 |
| 22,426 |
| 0 |
| 1,365 |
| 21,061 |
| 0.37 |
| 0.00 |
| - |
| - |
| 37.49 |
| 21,613 |
| 2025 |
|---|
| 12,747 |
| - |
| -20,928 |
| -20,928 |
| - |
| 100.00 |
| -164.18 |
| 1,498 |
| 30 |
| 984 |
| 544 |
| 0.04 |
| 0.02 |
| - |
| - |
| -155.46 |
| -19,817 |
| 2025 |
|---|
| 12,747 |
| - |
| -20,928 |
| -20,928 |
| - |
| 100.00 |
| -164.18 |
| 1,498 |
| 30 |
| 984 |
| 544 |
| 0.04 |
| 0.02 |
| - |
| - |
| -155.46 |
| -19,817 |
Turnover (€)
2025
Turnover (€)
12,747 €-78 % *
Sales per employee (€)
-Profit before tax (€)
-20,928 €-194 % *
Net Profit (€)
-20,928 €-194 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-164.18 %-523.91 % *
Equity (€)
1,498 €-93 % *
Amounts Payable And Liabilities (€)
30 €- *
Non-current Assets (€)
984 €-28 % *
CurrentAssets (€)
544 €-97 % *
Working capital requirement
0.04 -89.19 % *
Debt-to-equity ratio
0.02 - *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-155.46 %-514.67 % *
EBIT (€)
-19,817 €-192 % *
